Skip to content

Drug interactions

Carbamazepine + Elranatamab

Severity: Moderate

Carbamazepine and Elranatamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cytokine release after elranatamab can transiently suppress CYP enzymes and increase carbamazepine levels. This may cause toxicity such as dizziness, ataxia and confusion.

What this interaction means in plain words

Carbamazepine and Elranatamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Carbamazepine belongs to Central Nervous System; Elranatamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP3A4 activity during cytokine release syndrome.

What to do

Monitor for carbamazepine toxicity and consider checking levels during step-up dosing and for about two weeks afterward. Adjust the dose if levels rise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carbamazepine and Elranatamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Carbamazepine with Elranatamab?

MediHelp rates the interaction as moderate. Carbamazepine and Elranatamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cytokine release after elranatamab can transiently suppress CYP enzymes and increase carbamazepine levels. This may cause toxicity such as dizziness, ataxia and confusion.

How serious is the interaction between Carbamazepine and Elranatamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for carbamazepine toxicity and consider checking levels during step-up dosing and for about two weeks afterward. Adjust the dose if levels rise.

What other medicines interact with Carbamazepine?

MediHelp also lists interactions of Carbamazepine with, for example, Artemether / lumefantrine, Cabotegravir, Delamanid. The full list is on the Carbamazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in